tiprankstipranks
Trending News
More News >
Aeso Holding Limited (HK:8341)
:8341
Hong Kong Market

Aeso Holding Limited (8341) AI Stock Analysis

Compare
0 Followers

Top Page

HK:8341

Aeso Holding Limited

(8341)

Select Model
Select Model
Select Model
Neutral 50 (OpenAI - 4o)
Rating:50Neutral
Price Target:
HK$0.12
▼(-17.33% Downside)
Aeso Holding Limited's overall stock score is primarily impacted by its weak financial performance, characterized by declining revenues and profitability, high leverage, and negative cash flows. The technical analysis indicates a bearish trend, while the valuation suggests the stock might be undervalued. The absence of earnings call data and corporate events means these factors did not influence the score.
Positive Factors
Strategic Partnerships
These partnerships enhance Aeso's capabilities in product development and market entry, potentially leading to sustainable growth and innovation.
R&D Investment
Continuous R&D investment supports the introduction of new products, helping Aeso adapt to evolving consumer needs and maintain competitive advantage.
Gross Profit Margin Improvement
Improvement in gross profit margin indicates better cost management and pricing strategies, which can enhance profitability over time.
Negative Factors
Declining Revenue
A declining revenue trend suggests challenges in market demand or competition, which could impact long-term financial stability if not addressed.
High Leverage
Significant leverage poses financial risk, potentially limiting the company's ability to invest in growth opportunities and affecting financial stability.
Negative Cash Flows
Negative cash flows indicate liquidity challenges, which can constrain operational flexibility and investment capacity, impacting long-term growth.

Aeso Holding Limited (8341) vs. iShares MSCI Hong Kong ETF (EWH)

Aeso Holding Limited Business Overview & Revenue Model

Company DescriptionAeso Holding Limited (8341) is a diversified investment holding company based in Hong Kong, primarily engaged in the business of providing innovative healthcare solutions and services. The company's operations span across various sectors, including pharmaceuticals, biotechnology, and wellness products, focusing on enhancing the quality of life through advanced medical technologies and effective treatment options. Aeso Holding Limited aims to leverage its expertise and strategic partnerships to deliver cutting-edge healthcare products and services to a global market.
How the Company Makes MoneyAeso Holding Limited generates revenue through multiple key streams, primarily from the sale of healthcare products, including pharmaceuticals and wellness solutions. The company also earns income from licensing agreements and collaborations with other healthcare firms, which allow it to expand its product offerings and market reach. Additionally, Aeso may benefit from strategic partnerships with research institutions and healthcare providers, enhancing its capabilities in product development and market entry. The company's revenue model is further supported by its investment in research and development, which leads to the introduction of innovative products that meet evolving consumer needs in the healthcare sector.

Aeso Holding Limited Financial Statement Overview

Summary
Aeso Holding Limited faces financial challenges with declining revenues and profitability, high leverage, and negative cash flows. While there are slight improvements in gross profit margin, the overall financial health is weak, requiring strategic improvements to stabilize and grow.
Income Statement
45
Neutral
Aeso Holding Limited has shown a declining revenue trend with a significant drop of 30.4% in the latest year. Gross profit margin improved slightly to 17.5%, but net profit margin decreased to 2.8%. The EBIT and EBITDA margins are relatively low, indicating challenges in operational efficiency.
Balance Sheet
50
Neutral
The company has a high debt-to-equity ratio of 1.28, indicating significant leverage, which could pose financial risk. Return on equity has decreased to 11.4%, reflecting reduced profitability. The equity ratio is not provided, but the overall leverage suggests a cautious approach to financial stability.
Cash Flow
30
Negative
Aeso Holding Limited's cash flow situation is concerning, with negative operating and free cash flows. The free cash flow growth rate is significantly negative, and the operating cash flow to net income ratio is negative, indicating cash flow challenges.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue256.31M210.22M239.69M262.62M218.01M125.05M
Gross Profit45.42M36.76M37.50M35.95M29.91M15.83M
EBITDA11.95M12.85M13.53M12.54M11.20M-707.00K
Net Income6.52M5.91M8.11M8.26M8.16M-5.65M
Balance Sheet
Total Assets161.18M161.18M172.95M120.03M115.61M88.29M
Cash, Cash Equivalents and Short-Term Investments35.67M35.67M37.01M16.91M18.99M19.75M
Total Debt65.98M65.98M58.25M39.98M35.13M9.96M
Total Liabilities109.44M109.44M127.11M82.30M87.50M68.86M
Stockholders Equity51.74M51.74M45.84M37.73M28.11M19.43M
Cash Flow
Free Cash Flow-563.00K-563.00K-287.00K870.00K-19.30M-24.39M
Operating Cash Flow-358.00K-358.00K-278.00K1.36M-19.13M-24.32M
Investing Cash Flow-197.00K-197.00K-11.61M-5.47M735.00K-71.00K
Financing Cash Flow-1.38M-1.38M15.31M2.60M18.31M-2.54M

Aeso Holding Limited Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.15
Price Trends
50DMA
0.13
Positive
100DMA
0.13
Positive
200DMA
0.17
Negative
Market Momentum
MACD
<0.01
Negative
RSI
61.03
Neutral
STOCH
61.11
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:8341, the sentiment is Positive. The current price of 0.15 is above the 20-day moving average (MA) of 0.14, above the 50-day MA of 0.13, and below the 200-day MA of 0.17, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 61.03 is Neutral, neither overbought nor oversold. The STOCH value of 61.11 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:8341.

Aeso Holding Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
50
Neutral
HK$36.00M2.7610.44%-26.94%-38.23%
48
Neutral
HK$83.52M-7.77-601.82%4.00%13.57%
46
Neutral
HK$146.20M-5.51-57.83%-3.47%-57.53%
46
Neutral
HK$98.97M-12.63-5.93%50.50%27.48%
46
Neutral
HK$242.49M-6.06-24.93%-72.69%
41
Neutral
HK$24.76M-4.86-19.25%46.11%54.20%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:8341
Aeso Holding Limited
0.15
0.03
25.00%
HK:3893
CROSSTEC Group Holdings Ltd.
1.02
0.53
108.16%
HK:8040
Coolpoint Innonism Holding Limited
0.45
0.10
28.57%
HK:8173
Hephaestus Holdings Limited
0.12
-0.04
-25.00%
HK:8455
Lai Group Holding Co Ltd
0.09
0.07
350.00%
HK:8501
Sanbase Corporation Limited
0.49
0.15
44.12%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 30, 2025